All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Hereditary Cancer in Clinical Practice

ISSN Print: 1897-4287

ISSN Online:

Website: http://www.hccpjournal.com

Share:




Go

Close ties: an exploratory Colored Eco-Genetic Relationship Map (CEGRM) study of social connections of men in Familial Testicular Cancer (FTC) families

June A Peters, Regina Kenen, Lindsey M Hoskins, Gladys M Glenn, Christian Kratz, Mark H Greene

Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers

Ramunas Janavicius, Pavel Elsakov

The R337H mutation in TP53 and breast cancer in Brazil

Magda CB Gomes, Joanne Kotsopoulos, Gutemberg de Almeida, Mauricio M Costa, Roberto Vieira, Firmino de AG Filho, Marcos B Pitombo, Paulo F Leal, Robert Royer, Phil Zhang, Steven A Narod

Challenges in the management of a patient with Cowden syndrome: case report and literature review

Inga Melbārde-Gorku？a, Arvīds Irmejs, Dace Bērzi？a, Ilze ？trumfa, Arnis āboli？？, Andris Gardovskis, Signe Subatniece, Genādijs Trofimovi？s, Jānis Gardovskis, Edvīns Mikla？evi？s

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome

Ani Kardashian, Julia Fehniger, Jennifer Creasman, Eleanor Cheung, Mary Beattie

Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon

Nadine Jalkh, Jinane Nassar-Slaba, Eliane Chouery, Nabiha Salem, Nancy Uhrchammer, Lisa Golmard, Dominique Stoppa-Lyonnet, Yves-Jean Bignon, Andre Megarbane

Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations

Katarina Bartuma, Mef Nilbert, Christina Carlsson

Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history

Carmen M Radecki Breitkopf, Pamela S Sinicrope, Kari G Rabe, Tabetha A Brockman, Christi A Patten, Robert R McWilliams, Shawna L Ehlers, Gloria M Petersen

Referral of Queensland women with endometrial cancer to genetic services

Tan YY,McGaughran J,Obermair A,Spurdle A

Iron and breast cancer risk

Sukiennicki Grzegorz,Muszyńska Magdalena,Huzarski Tomasz,Gronwald Jacek

Microelements as risk factors for cancer of the lung and larynx

Jaworska-Bieniek Katrzyna,Gupta Satish,Durda Katarzyna,Muszynska Magdalena

The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study

Hosein AN,Cocciardi S,Jayanthan J,Song S

Genetic alterations and field defect in head and neck squamous cell carcinoma

Strzelczyk J K,Krakowczyk ？,Kwa？niewski M,P？achetka A

Clinical genetics in cancer prevention

Elsakov Pavel

Improving the provision of Melbourne Health Familial Cancer services to Victoria’s Culturally and Linguistically Diverse (CALD) communities

Bylstra Y,Kentwell M,Lindeman GJ,Winship I

Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer

Beesley Jonathan,Pickett Hilda,Johnatty Sharon,Chen Xiaoqing

Prostate cancer screening based on genotyping for high risk founder alleles

Cybulski Cezary,Woko？orczyk Dominika,Klu？niak Wojciech,Lubiński Jan

The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer

Banaszkiewicz Monika,Constantinou Maria,Pietrusiński Micha？,K？pczyński ？ukasz

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer

Bar Julia K,Lis-Nawara Anna,Lebioda Arleta,Jonkisz Anna

Folic acid and breast cancer risk

Durda Katarzyna,Jaworska-Bieniek Katrzyna,K？klewski Krzysztof,Lubiński Jan

NBS1 Mutation and prognosis of prostate cancer

Woko？orczyk Dominika,Klu？niak Wojciech,Cybulski Cezary,Lubiński Jan

Overview of genetic markers for hereditary colorectal cancer

Scott Rodney J

Cumulative small effect genetic markers and the detection of advanced colorectal neoplasias by population screening

Kurlapska A,Serrano-Fernández P,Starzyńska T,Ma？ecka-Panas E

Selenium (Se) and breast cancer risk

Jaworska - Bieniek Katarzyna,Jakubowska Anna,Durda Katarzyna,Huzarski Tomasz

Systemic therapy for hereditary cancer

Imyanitov Evgeny N

Zinc and breast cancer risk

Kaczmarek Katarzyna,Jakubowska Anna,Sukiennicki Grzegorz,Muszyńska Magdalena

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland

Plawski Andrzej,Boruń Pawe？,Banasiewicz Tomasz,Paszkowski Jacek

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer

Huzarski T T,Górecka-Szyld B,Huzarska J J,Psut G

BRCA1 testing in Lithuania

Janavicius Ramunas

Arsenic (As) and breast cancer risk

Muszyńska Magdalena,Jaworska-Bieniek Katarzyna,Durda Katarzyna,Sukiennicki Grzegorz

Diagnostic microarray test for a genetic predisposition to hereditary nonpolyposis colorectal cancer (HNPCC)

Kaszuba M,Sikorski A,Odwa？na J,Wojciechowicz J

HOXB13 mutations and prostate cancer in Poland

Klu？niak Wojciech,Woko？orczyk Dominika,Lubiński Jan,Cybulski Cezary

Impact of BRCA1 mutation on survival after early onset breast cancer

Huzarski T,Byrski T,Gronwald J,Górski B

Cisplatin in breast cancer treatment in BRCA1 carriers

Gronwald Jacek,Byrski Tomasz,Lubinski Jan,Narod Steven A

Selenium and gastrointestinal cancers risk

Lener Marcin,Jakubowska Anna,Wiechowska-Koz？owska Anna,K？adny Józef

Design considerations for massively parallel sequencing studies of common familial cancers

Feng BJ,Tavtigian SV,Southey MC,Goldgar DE

Expanded genetic analysis of a PALB2 c.3113G>A mutation carrying multiple-case breast cancer family via exome sequencing

Teo ZL,Park DJ,Odefrey F,Hammet F

Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy

Chenevix-Trench Georgia,Lu Yi,Johnatty Sharon,Gamazon Eric

A case of late breast cancer metastases to both suprarenal glands 28 years after mastectomy

Banasiewicz T,Krokowicz ？,Biczysko M,Janicka-Jedyńska M

Effects of X-ray irradiation on methylation levels of p16, MGMT and APC genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa

Krakowczyk ？ukasz,Strzelczyk Joanna K,Blamek S？awomir,Maciejewski Adam

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?

Byrski T,Huzarski T,Marczyk E,Blecharz P

The relationship between the BRAF p.V600E mutation and a family history of CRC in the early-onset CRC cases from the Australasian Colon Cancer Family Study

Buchanan DD,Win AK,Walters R,Walsh MD

Early exploration of two candidate breast cancer susceptibility genes identified by whole-exome sequencing

Blanc R,Jammot A,Nguyen-Dumont T,Teo ZL

Large genomic rearrangements in BRCA1 and BRCA2 genes in breast and ovarian cancer families in Poland

Bielecka Helena,Górski Bohdan

Are women at high risk for serous gynaecological cancer (SGC) opting for risk-reducing salphingo-oophorectomy motivated by high levels of anxiety and risk perceptions?

Meiser B,Price MA,Butow PN,Karatas J

Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays

Heinen Christopher D,Juel Rasmussen Lene

Selenium (Se) and the risk of breast, ovarian and prostate cancers

Jaworska Katarzyna,Jakubowska Anna,Durda Katarzyna,Huzarski Tomasz

Whole genome sequencing in the study of disease and application in personalised medicine

Kumarasuriyar A

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers

Gabra H

Genome-wide association studies identify new melanoma susceptibility loci

D？bniak Tadeusz

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705